Risk stratification for hepatocellular carcinoma of contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) and the diagnostic performance of LR-5 and LR-M: a systematic review and meta-analysis
Authors:
- 12 February 2022
- journal article
- review article
- Published by Elsevier in Clinical Radiology
- Vol. 77 (4) , e280-e286
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Evaluation of Contrast-enhanced US LI-RADS version 2017: Application on 2020 Liver Nodules in Patients with Hepatitis B InfectionRadiology, 2020
- The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data systemEuropean Journal of Radiology, 2019
- Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy—A Systematic ReviewGastroenterology, 2019
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinomaJournal of Hepatology, 2018
- Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodulesJournal of Hepatology, 2018
- Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy StudiesJAMA, 2018
- Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADSEuropean Journal of Gastroenterology & Hepatology, 2017
- AASLD guidelines for the treatment of hepatocellular carcinomaHepatology, 2017
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Systematic review: evidence‐based management of hepatocellular carcinoma – an updated analysis of randomized controlled trialsAlimentary Pharmacology & Therapeutics, 2006